NextCure, Inc. - stock earnings
NXTC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -14.3 million USD | ? USD |
| 2023Q2 | -17.9 million USD | ? USD |
| 2023Q1 | -15.1 million USD | ? USD |
| 2022Q4 | -16.8 million USD | ? USD |
| 2022Q3 | -18.6 million USD | ? USD |
| 2022Q2 | -17.7 million USD | ? USD |
| 2022Q1 | -20.4 million USD | ? USD |
| 2021Q4 | -16.9 million USD | ? USD |
| 2021Q3 | -17.9 million USD | ? USD |
| 2021Q2 | -18.0 million USD | ? USD |
| 2021Q1 | -16.5 million USD | ? USD |
| 2020Q4 | -15.5 million USD | ? USD |
| 2020Q3 | -16.4 million USD | ? USD |
| 2020Q2 | -14.5 million USD | ? USD |
| 2020Q1 | 9.7 million USD | 22.4 million USD |
| 2019Q4 | -10.9 million USD | 2.0 million USD |
| 2019Q3 | -8.4 million USD | 1.6 million USD |
| 2019Q2 | -8.2 million USD | 1.4 million USD |
| 2019Q1 | -6.2 million USD | 1.4 million USD |
| 2018Q4 | -6.9 million USD | ? USD |
| 2018Q3 | -5.7 million USD | ? USD |
| 2018Q2 | -5.2 million USD | ? USD |
| 2018Q1 | -5.0 million USD | ? USD |
NXTC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -65.6 million USD | ? USD |
| 2022 | -69.4 million USD | ? USD |
| 2021 | -69.4 million USD | ? USD |
| 2020 | -33.2 million USD | 22.4 million USD |
| 2019 | -33.7 million USD | 6.3 million USD |
| 2018 | -22.8 million USD | ? USD |
| 2017 | -15.5 million USD | ? USD |
NXTC
Price: $1.30
52 week price:
Earnings Per Share: -2.25 USD
P/E Ratio: -0.56
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 224200
Market Capitalization: 60.8 million